Company
Indaptus Therapeutics, Inc. (INDP)
Standardized SEC financial data for Indaptus Therapeutics, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001857044 · NASDAQ · Pharmaceutical Preparations.
Return on equity
-661.5%
Free cash flow
-$14.8M
Current ratio
1.51×
EPS (diluted)
$-21.58
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| R&D expense | $2.7M | $2.5M | $6.3M | $7.6M | $7.3M | $9.3M |
| SG&A expense |
Balance sheet
| USD | FY2022 | FY2023 | FY2024 | FY2025 | FY2025 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $9.6M | $13.4M | $5.8M | — | — | $8.5M |
| Total current assets |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$3.3M | -$11.3M | -$13.1M | -$13.4M | -$12.3M | -$14.8M |
| Capital expenditures |
Get INDP data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/INDP/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/INDP/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"